CoChat

Tumor suppressor p53 negatively regulates glycolysis stimulated by hypoxia through its target RRAD

Open access
Zhang, Cen, Liu, Juan, Wu, Rui, Liang, Yingjian, Lin, Meihua, Liu, Jia, Chan, Chang S., Hu, Wenwei, Feng, Zhaohui · 2014 · Oncotarget
Cited by 97

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

// Cen Zhang 1,* , Juan Liu 1,* , Rui Wu 1 , Yingjian Liang 1 , Meihua Lin 1 , Jia Liu 1 , Chang S. Chan 2 , Wenwei Hu 1 and Zhaohui Feng 1 1 Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, Rutgers, State University of New Jersey, New Brunswick, USA 2 Department of Medicine, Rutgers Cancer Institute of New Jersey, Rutgers, State University of New Jersey, New Brunswick, USA * These two authors contributed equally to this work Correspondence: Wenwei Hu, email: // Zhaohui Feng, email: // Keywords : p53, glycolysis, RRAD, hypoxia, lung cancer Received : May 17, 2014 Accepted : June 24, 2014 Published : June 26, 2014 Abstract Cancer cells display enhanced glycolysis to meet their energetic and biosynthetic demands even under normal oxygen concentrations. Recent studies have revealed that tumor suppressor p53 represses glycolysis under normoxia as a novel mechanism for tumor suppression. As the common microenvironmental stress for tumors, hypoxia drives the metabolic switch from the oxidative phosphorylation to glycolysis, which is crucial for survival and proliferation of cancer cells under hypoxia. The p53’s role and mechanism in regulating glycolysis under hypoxia is poorly understood. Here, we found that p53 represses hypoxia-stimulated glycolysis in cancer cells through RRAD, a newly-identified p53 target. RRAD expression is frequently decreased in lung cancer. Ectopic expression of RRAD greatly reduces glycolysis whereas knockdown of RRAD promotes glycolysis in lung cancer cells. Furthermore, RRAD represses glycolysis mainly through inhibition of GLUT1 translocation to the plasma membrane. Under hypoxic conditions, p53 induces RRAD, which in turn inhibits the translocation of GLUT1 and represses glycolysis in lung cancer cells. Blocking RRAD by siRNA greatly abolishes p53’s function in repressing glycolysis under hypoxia. Taken together, our results revealed an important role and mechanism of p53 in antagonizing the stimulating effect of hypoxia on glycolysis, which contributes to p53’s function in tumor suppression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.2137

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Research works printed but not linked: 27

  1. Warburg, 1956, On the origin of cancer cells, Science, 123, 309, 10.1126/science.123.3191.309 · DOI · Paper page
  2. Vousden, 2010, p53 regulation of metabolic pathways, Cold Spring Harb Perspect Biol, 2, a001040
  3. Feng, 2006, The P53 pathway: what questions remain to be explored?, Cell Death Differ, 13, 1027, 10.1038/sj.cdd.4401910 · DOI · Paper page
  4. Levine, 2010, The regulation of energy metabolism and the IGF-1/mTOR pathways by the p53 protein, Trends in cell biology, 20, 427, 10.1016/j.tcb.2010.03.004 · DOI · Paper page
  5. Gu, 2006, p53 aerobics: the major tumor suppressor fuels your workout, Cell Metab, 4, 1, 10.1016/j.cmet.2006.06.004 · DOI
  6. Gillies, 2004, Why do cancers have high aerobic glycolysis?, Nature reviews Cancer, 4, 891, 10.1038/nrc1478 · DOI · Paper page
  7. Dang, 2007, Effects of hypoxia on tumor metabolism, Cancer Metastasis Rev, 26, 291, 10.1007/s10555-007-9060-4 · DOI
  8. Vasseur, 2013, Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma, Proc Natl Acad Sci U S A, 110, 3919, 10.1073/pnas.1219555110 · DOI · Paper page
  9. Kahn, 1993, Rad: a member of the Ras family overexpressed in muscle of type II diabetic humans, Science, 262, 1441, 10.1126/science.8248782 · DOI · Paper page
  10. Kahn, 1996, Overexpression of Rad inhibits glucose uptake in cultured muscle and fat cells, The Journal of biological chemistry, 271, 23111, 10.1074/jbc.271.38.23111 · DOI · Paper page
  11. Chou, 2011, Rad is a p53 direct transcriptional target that inhibits cell migration and is frequently silenced in lung carcinoma cells, J Mol Med (Berl), 89, 481, 10.1007/s00109-010-0717-z · DOI
  12. Gazdar, 2007, Methylation and gene silencing of the Ras-related GTPase gene in lung and breast cancers, Ann Surg Oncol, 14, 1397, 10.1245/s10434-006-9089-6 · doi:10.1245/s10434-006-9089-6
  13. Holman, 1994, Inhibition of the translocation of GLUT1 and GLUT4 in 3T3-L1 cells by the phosphatidylinositol 3-kinase inhibitor, wortmannin, Biochem J, 300, 631
  14. Ebina, 2000, Activation of G-protein coupled fMLP or PAF receptor directly triggers glucose transporter type 1 (GLUT1) translocation in Chinese hamster ovary (CHO) cells stably expressing fMLP or PAF receptor, J Med Invest, 47, 19
  15. Cagle, 1997, Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival, Cancer, 80, 1046, 10.1002/(SICI)1097-0142(19970915)80:6<1046::AID-CNCR6>3.0.CO;2-7 · DOI · Paper page
  16. Sakuma, 2010, Correlation between glucose transporter-1 expression and 18F-fluoro-2-deoxyglucose uptake on positron emission tomography in lung cancer, Gen Thorac Cardiovasc Surg, 58, 405, 10.1007/s11748-010-0603-1 · DOI
  17. Prasad, 2009, Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond, Pharmacol Ther, 121, 29, 10.1016/j.pharmthera.2008.09.005 · DOI · Paper page
  18. Karnieli, 2004, The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression, Cancer Res, 64, 2627, 10.1158/0008-5472.CAN-03-0846 · DOI · Paper page
  19. Yustein, 2008, The interplay between MYC and HIF in cancer, Nat Rev Cancer, 8, 51, 10.1038/nrc2274 · DOI · Paper page
  20. Simon, 2007, HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation, Cancer Cell, 12, 108, 10.1016/j.ccr.2007.07.006 · DOI · Paper page
  21. Kahn, 1997, Rad and Rad-related GTPases interact with calmodulin and calmodulin-dependent protein kinase II, The Journal of biological chemistry, 272, 11832, 10.1074/jbc.272.18.11832 · DOI
  22. Hunziker, 2006, Nuclear sequestration of beta-subunits by Rad and Rem is controlled by 14-3-3 and calmodulin and reveals a novel mechanism for Ca2+ channel regulation, J Mol Biol, 355, 34, 10.1016/j.jmb.2005.10.013 · DOI
  23. Andres, 2003, Regulation of voltage-gated calcium channel activity by the Rem and Rad GTPases, Proc Natl Acad Sci U S A, 100, 14469, 10.1073/pnas.2437756100 · DOI · Paper page
  24. Zhu, 2011, Rad GTPase inhibits cardiac fibrosis through connective tissue growth factor, Cardiovascular research, 91, 90, 10.1093/cvr/cvr068 · DOI
  25. Klip, 1991, Differential regulation of the GLUT-1 and GLUT-4 glucose transport systems by glucose and insulin in L6 muscle cells in culture, The Journal of biological chemistry, 266, 2615, 10.1016/S0021-9258(18)52289-4 · DOI · Paper page
  26. Cushman, 1983, Insulin-stimulated translocation of glucose transporters in the isolated rat adipose cells: characterization of subcellular fractions, Biochim Biophys Acta, 763, 393, 10.1016/0167-4889(83)90101-5 · DOI · Paper page
  27. Giorgino, 2004, Dehydroepiandrosterone stimulates glucose uptake in human and murine adipocytes by inducing GLUT1 and GLUT4 translocation to the plasma membrane, Diabetes, 53, 41, 10.2337/diabetes.53.1.41 · DOI · Paper page

Cited by

Metadata

Authors
Zhang, C., Liu, J., Wu, R., Liang, Y., Lin, M., Liu, J., Chan, C. S., Hu, W., & Feng, Z.
Venue
Oncotarget
Published
2014-06-26
Volume
5
Issue
14
Pages
5535-5546
ISSN
1949-2553 (ISSN-L)
OpenAlex
W1556134345
Cited by
97
References
16
FWCI
2.24
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.